XLO
Xilio Therapeutics, Inc.
Recent 8-K filings for XLO
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 12, 2026 11:35 UTC earnings item 2.02item 9.01
Xilio Q1 net loss $9.5M; cash $150.3M; XTX501 IND planned mid-2026
source · XLO on sec.gov